BALCHEM CORP filed this 8-K on April 24, 2025
BALCHEM CORP - 8-K - 20250424 - CASH_FLOW
Balchem Corporation
Condensed Consolidated Statements of Cash Flows
(Dollars in thousands)
(unaudited)
Three Months Ended March 31,
20252024
Cash flows from operating activities:
   Net earnings $37,053 $28,986 
   Adjustments to reconcile net earnings to net cash provided by operating
      activities:
        Depreciation and amortization11,014 13,668 
        Stock compensation expense 3,810 4,750 
        Other adjustments (105)(949)
        Changes in assets and liabilities(15,315)(13,067)
  Net cash provided by operating activities36,457 33,388 
 
Cash flows from investing activities:
   Capital expenditures and intangible assets acquired(5,559)(6,910)
   Cash paid for acquisitions, net of cash acquired(323)— 
   Proceeds from the sale of assets— 213 
   Investment in affiliates(30)(42)
  Net cash used in investing activities(5,912)(6,739)
Cash flows from financing activities:
   Proceeds from revolving loan29,000 26,000 
   Principal payments on revolving loan(29,000)(34,000)
   Principal payments on finance leases(49)(57)
   Proceeds from stock options exercised1,668 8,791 
   Dividends paid(28,263)(25,555)
   Repurchases of common stock(5,325)(5,202)
  Net cash used in financing activities(31,969)(30,023)
   Effect of exchange rate changes on cash1,810 (724)
Increase (decrease) in cash and cash equivalents386 (4,098)
Cash and cash equivalents, beginning of period49,515 64,447 
Cash and cash equivalents, end of period$49,901 $60,349